STEVEN C. QUAY - 02 Mar 2023 Form 4 Insider Report for ATOSSA THERAPEUTICS, INC. (ATOS)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATOS	Stock Option (right to buy)	Award	$0	+1.87M		$0.00	1.87M	02 Mar 2023	Common Stock	1.87M	$0.72	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The option will vest and become exercisable on a quarterly basis over 24 months from the grant-date.